We deliver risk-oriented, audit-ready regulatory compliance design dedicated to all types of bioprocessing facilities, covering biologic drugs, vaccines, sterile injectables, cell & gene therapy and microbial fermentation production lines. All design schemes fully align with FDA cGMP, EMA Annex 1, PIC/S, ISPE Baseline Guides and local pharmaceutical regulatory codes worldwide.
Our compliance design runs through the entire engineering cycle from early-stage conceptual planning to detailed construction drawing, with quality risk management (QRM) embedded in every layout and system. We address core regulatory requirements including Grade A/B/C/D cleanroom zoning, unidirectional segregation of personnel and material flow, cross-contamination prevention, biosafety isolation for live organisms, closed bioprocess transfer systems, and complete environmental monitoring infrastructure.
Specialized compliant utility design is included: WFI & pure steam distribution, sanitary 316L process piping, fully automated CIP/SIP circuits, differential pressure controlled HVAC, BMS/EMS real-time particle and microbial monitoring, as well as dedicated waste inactivation and drainage systems. We compile supporting compliance documents such as Contamination Control Strategy (CCS), Risk Assessment Reports and Design Qualification (DQ) outlines to directly support subsequent CQV and official regulatory inspections.
Our design solutions adapt to greenfield commercial plants, modular pilot bioprocess workshops and GMP renovation of legacy facilities. By resolving non-compliant design defects in advance, we eliminate expensive post-construction reconstruction, shorten validation cycles and greatly improve the pass rate of global regulatory audits.
